Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 3
2005 2
2006 1
2007 2
2008 2
2009 5
2010 5
2011 3
2012 2
2013 4
2014 2
2015 5
2016 1
2017 3
2018 1
2019 2
2020 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

42 results
Results by year
Filters applied: . Clear all
Page 1
Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapy.
Barkal AA, Weiskopf K, Kao KS, Gordon SR, Rosental B, Yiu YY, George BM, Markovic M, Ring NG, Tsai JM, McKenna KM, Ho PY, Cheng RZ, Chen JY, Barkal LJ, Ring AM, Weissman IL, Maute RL. Barkal AA, et al. Nat Immunol. 2018 Jan;19(1):76-84. doi: 10.1038/s41590-017-0004-z. Epub 2017 Nov 27. Nat Immunol. 2018. PMID: 29180808 Free PMC article.
Normal and Neoplastic Stem Cells.
McCracken MN, George BM, Kao KS, Marjon KD, Raveh T, Weissman IL. McCracken MN, et al. Cold Spring Harb Symp Quant Biol. 2016;81:1-9. doi: 10.1101/sqb.2016.81.030965. Epub 2017 Apr 17. Cold Spring Harb Symp Quant Biol. 2016. PMID: 28416577 Free PMC article. Review.
Macrophages as mediators of tumor immunosurveillance.
Jaiswal S, Chao MP, Majeti R, Weissman IL. Jaiswal S, et al. Trends Immunol. 2010 Jun;31(6):212-9. doi: 10.1016/j.it.2010.04.001. Epub 2010 May 7. Trends Immunol. 2010. PMID: 20452821 Free PMC article. Review.
42 results